CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 396 enrolled
Drug / intervention
Next Generation ORS (oral rehydration solution) (including placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05814042
NCT05814042Phase 3Completed
CompareCT.gov

Next Generation ORS: Randomized Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity With Acute Watery Diarrhea in Adults

University of Florida·interventional·Posted Apr 14, 2023·Updated Apr 14, 2026

In Brief

A Phase 3 clinical trial evaluating Next Generation ORS (oral rehydration solution) (including placebo and Current standard control ORS (oral rehydration solution) for Diarrhea and Cholera. Completed, enrolled 396 participants across 1 site.

Detailed Summary

Diarrhea remains a leading killer of children in need of better treatments.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhea, Cholera
CountriesBangladesh
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

Phase 3CompletedFinished
202420252026
First PostedApr 14, 2023
Enrollment StartAug 21, 2023
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.2 years ago

Interventions

Next Generation ORS (oral rehydration solution) (including placebodrug

Nutrition used to stop diarrhea

Current standard control ORS (oral rehydration solution)drug

current standard control ORS in diarrheic patients with cholera